Advocates Aren’t Happy About Drug-Patent Language in the Updated UNAIDS Document That Sets the Global AIDS Agenda
They say the U.S. nixed terminology that would have made it easier for middle- and low-income countries to manufacture and obtain less expensive HIV drugs—despite Biden’s COVID patent signals.
Like the treatment divide of the early HIV/AIDS crisis, the uneven distribution of COVID-19 vaccines poses a global threat.
In the wake of a brutal alleged murder, activists have united to repeal HIV criminalization laws, get hate crime legislation on the books, and fill gaps in HIV treatment access.
With its powerful former head Deborah Birx, M.D., now retired after her Trump-era COVID fumble, the program awaits a new top dog—and perhaps a new life.
Alleged corruption has caused countless health risks and an increase in stigma against condom use in Zambia, where HIV rates are still high.
European organizations weigh in on what’s worked for home testing programs over the past year.
Data leaks can lead to missed medications, illness, HIV drug resistance, and even worse stigma against people living with HIV.
A new U.K.-based initiative is creating a groundswell of action around the sexual health of queer men of color.
Five HIV/AIDS services providers in the West African country discuss how they’re getting antiretrovirals to patients and meeting other immediate needs during the pandemic.
The pandemic has disrupted HIV care all over the world, causing missed doses of medications and lack of access to clinics.